Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 101

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 101
---
, merger, consolidation or other reorganization (or, if applicable, more than fifty         
 percent (50%) of the combined voting power of the ultimate parent company that directly or indirectly has beneficial ownership of          
 the securities of such continuing or surviving entity) is not owned directly or indirectly by persons who were holders of the Company’s    
 then-outstanding voting securities immediately prior to such amalgamation, merger, consolidation or other reorganization;                  |
| (2) | The                                                                                                                                        
 sale, transfer or other disposition of all or substantially all of the Company’s assets to an entity that is not a parent,                 
 a Subsidiary or an Affiliate of the Company;                                                                                               |
| (3) | Any                                                                                                                                        
 transaction as a result of which any person becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange                    
 Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented 
 by the Company’s then-outstanding voting securities. For purposes of this subsection, the term “person” shall have                         
 the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude: (i) any parent, Subsidiary or Affiliate   
 of the Company; (ii) any employee benefit plan (or related trust) sponsored or maintained by the Company, a parent, or any Subsidiary      
 or Affiliate; and (iii) any underwriter temporarily holding securities pursuant to an offering of such securities;                         |

| (4) | A                                                                                                                                    
 change in the composition of the Board over a period of twenty four (24) consecutive months or less as a result of which individuals 
 who, at the beginning of such period, constitute the Board (the “Incumbent Board”) cease for any reason to constitute                
 at least a majority of the Board; provided, however, that any individual subsequently becoming a director whose election,            
 or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of the directors then        
 comprising the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named   
 as a nominee for director, without written objection to such nomination) shall be considered as though such individual were a member 
 of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result   
 of either an actual or threatened